Last reviewed · How we verify
NCT03896672
Clinical Implementation of the Use of Positive Pressure in Chest Drainage
NA trial testing Continuous Positive Airway Pressure in Pleural Effusion in 64 participants. Completed in 31 January 2023.
31 January 2021
Quick facts
| Lead sponsor | Universidade Cidade de Sao Paulo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 64 |
| Start date | 1 September 2019 |
| Primary completion | 31 January 2021 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Continuous Positive Airway Pressure
Conditions studied
- Pleural Effusion — all drugs for Pleural Effusion →
Sponsor
Universidade Cidade de Sao Paulo
Who can join
Adults 18 to 85, any sex, with Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Scientific evidence appoints that the use of non-invasive positive airway pressure in pleural effusion drainage patients is associated with a reduction in these complications, as well as with other benefits. Objectives: To test the implementation of the best evidence-based practices for the use of non-invasive continuous positive airway pressure (CPAP) in patients with chest drainage for pleural effusion, by acceptability, reach, appropriateness, direct costs, feasibility, fidelity, penetration, and sustainability. In addition, to assess the impact of implementing these practices on health-related outcomes of patients having their pleural effusion drained through dwelling time of the chest tube, hospital stay and others relevant outcomes. Methods: quasi-experimental study with pretest-posttest design. Eight hospitals that provide physiotherapeutic care to pleural effusion drainage patients will be involved. The study will be developed in three phases. In phase I, a audit team will help the local research team to elaborate strategies to cope with barriers related to the use of CPAP in patients with pleural effusion and catheter drainage, using a interview with the physical therapist, patient history analysis, and interviews with the patients. In implementation phase, the results obtained from phase I will be presented to physiotherapists to physiotherapists and a discussion will be started on the evidence regarding the best practices in the application of CPAP for educational purposes only. In phase III, new interviews will be held with the physical therapist and patients and the patient histories will be analyzed to assess the impact of the intervention 30 days after implementation phase.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Use of continuous positive airway pressure in drainage of pleural effusion: Educational intervention for evidence-based practice.
Santos EDCD, Mendes A, Ohara DG, Silva HVC, et al · · 2024 · PMID 39316892 · DOI 10.1016/j.clinsp.2024.100499
Verify or expand the search:
- PubMed search for NCT03896672
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous Positive Airway Pressure
Trials testing the same drug.
- NCT07247318 — The Effects of Different Non-invasive Respiratory Support · NA · not yet recruiting
- NCT06795971 — Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intub · NA · recruiting
- NCT06512779 — Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals · NA · recruiting
- NCT06391138 — The Effect of OSA on Pregnancy and Fetal Outcomes · not yet recruiting
- NCT06393023 — The Effect of OSA on Severity and Prognosis of Patients With CKD · not yet recruiting
Other recruiting trials for Pleural Effusion
Currently open trials in the same condition.
- NCT07248774 — Effect of Bubble Positive Expiratory Pressure and Segmental Breathing Versus Incentive Spirometry in Pleural Effusion · NA · recruiting
- NCT07012759 — Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients · recruiting
- NCT06958848 — 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy · NA · recruiting
- NCT06892691 — Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions · NA · recruiting
- NCT06314620 — Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency · NA · recruiting
Other Universidade Cidade de Sao Paulo trials
Trials by the same sponsor.
- NCT05904925 — Pilates for the Prevention of Musculoskeletal Complaints During Pregnancy · NA · unknown
- NCT05575089 — Inspiratory Muscle Training and Pulmonary Function in Patients Submitted to Bariatric Surgery · NA · completed
- NCT04274439 — Effectiveness and Cost-Effectiveness of a Tele-Rehabilitation Program in the Treatment of Chronic Musculoskeletal Pain · NA · unknown
- NCT04114422 — A Seven-day Preoperative Exercise Training Program in People With Abdominal Cancer · NA · withdrawn
- NCT06341244 — Air Stacking Technique Efficacy on Peak of Expiratory Flow and Cough Peak Flow in Non-cardiac Thoracic Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03896672 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Cidade de Sao Paulo
- Last refreshed: 3 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03896672.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing